2020 Impact Of Covid-19 On The Bi-Specific MAbS Market Growth And Trends

The Business Research Company published its Bi-Specific MAbS Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Bi-Specific MAbS market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.

The report covers the Bi-Specific MAbS market’s segments-

1) By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597

2) By Product Type: In Vivo, In Vitro

3) By Indication: Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others

4) By End Use: Hospitals, Research Institutes, Others.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/bi-specific-mabs-market-global-report-2020-30-covid-19-growth-and-change

Bi-Specific MAbS Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

The global bi-specific MAbs market was valued at about $1.56 billion in 2019 and is expected to grow to $2.93 billion in 2020 at a compound annual growth rate (CAGR) of 87.6%. The COVID-19 restrictions caused a slowdown in growth due to missed patient visits affecting potential new patients who deferred the care, whereas existing patients remained on their treatment. However, with the sales beginning to recover slowly, the market is expected to stabilize and reach $6.12 billion by 2023 at a CAGR of 27.8%.

Companies in the bi-specific MAbS market are increasingly investing in various strategic initiatives such as collaborations and partnerships to expand the product portfolio and geographical presence of the company.

Few Points From Table Of Content  

1. Executive Summary
2. Report Structure
3. Bi-Specific MAbS Market Characteristics
4. Bi-Specific MAbS Market Product Analysis
5. Bi-Specific MAbS Market Supply Chain
……
26. Key Mergers And Acquisitions In The Bi-Specific MAbS Market

27. Bi-Specific MAbS Market Trends And Strategies

28. Bi-Specific MAbS Market Future Outlook and Potential Analysis

29. Appendix

 Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3390&type=smp

 Few Points From List Of Table 

Table 1: Global Historic Market Growth, 2015-2019, $ Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 3: Global Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 4: Global Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 5: Global Bi-Specific MAbS Market, Segmentation By Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

…….. 
Table 47: Johnson & Johnson Financial Performance

Table 48: Novartis AG Financial Performance

Table 49: Hoffmann-La Roche Ltd. Financial Performance

Table 50: Novo Nordisk A/S Financial Performance

Table 51: Bayer AG Financial Performance

 About The Business Research Company: 

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.  
 

Contact Information: 
The Business Research Company 
Europe: +44 207 1930 708 
Asia: +91 8897263534 
Americas: +1 315 623 0293 
Email: info@tbrc.info